CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 129 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $33,306 | -45.6% | 19,364 | -52.3% | 0.00% | – |
| Q1 2023 | $61,277 | -7.8% | 40,581 | -2.4% | 0.00% | – |
| Q4 2022 | $66,494 | +23.1% | 41,559 | +107.2% | 0.00% | – |
| Q1 2022 | $54,000 | -33.3% | 20,061 | +6.6% | 0.00% | – |
| Q4 2021 | $81,000 | -84.9% | 18,820 | -77.8% | 0.00% | – |
| Q2 2021 | $536,000 | +300.0% | 84,724 | +387.1% | 0.00% | – |
| Q1 2021 | $134,000 | +32.7% | 17,394 | +13.3% | 0.00% | – |
| Q4 2020 | $101,000 | -20.5% | 15,349 | -19.9% | 0.00% | – |
| Q3 2020 | $127,000 | -5.2% | 19,160 | +19.5% | 0.00% | – |
| Q2 2020 | $134,000 | – | 16,039 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 524,763 | $7,924,000 | 3.84% |
| Congress Park Capital LLC | 123,311 | $1,862,000 | 2.05% |
| Perceptive Advisors | 2,911,715 | $43,588,000 | 1.66% |
| RTW INVESTMENTS, LP | 908,586 | $13,720,000 | 1.28% |
| HAMILTON LANE ADVISORS LLC | 68,753 | $1,038,000 | 0.91% |
| HARBOURVEST PARTNERS LLC | 79,193 | $1,196,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 273,151 | $4,125,000 | 0.46% |
| Exane Asset Management | 50,000 | $755,000,000 | 0.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 622,548 | $9,400,000 | 0.38% |
| Cormorant Asset Management, LP | 296,712 | $4,480,000 | 0.36% |